Name: 글로벌 시장 동향
SKU: BT7684
Availability: InStock

보고서 요약(국문)

개요
글로벌 전장 유전체 시퀀싱 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
염기 서열을 결정하는 과정을 시퀀싱이라고 합니다. 전장 유전체 시퀀싱은 실험실에서 한 번의 작업으로 생물체의 유전체 내 염기 서열을 결정하는 과정입니다. 전장 유전체 시퀀싱(WGS)은 전체 유전체를 분석하는 완벽한 기술입니다. 유전체 데이터는 유전 질환 진단, 암 진행을 유발하는 돌연변이 추적, 감염병 발생 추적 등에 중요한 역할을 해왔습니다.
시장 동향: 성장 동인 및 제약 요인
첨단 제품 출시 증가
시장에 첨단 제품이 점점 더 많이 출시됨에 따라 예측 기간 동안 글로벌 시장 성장이 촉진될 것으로 예상됩니다. 예를 들어, 2022년 9월 일루미나(Illumina, Inc.)는 NovaSeq X Plus와 NovaSeq X를 포함한 NovaSeq X 시리즈 플랫폼을 출시했습니다. 이 생산 규모 시퀀서는 연간 약 2만 개의 전체 게놈을 분석할 수 있으며, 이는 기존 시퀀서보다 2.5배 높은 처리량입니다. 또한, 2023년 1월에는 Qiagen Digital Insights(QDI)가 클라우드 컴퓨팅 비용 약 1달러로 25분 만에 전체 게놈 데이터를 분석할 수 있는 Qiagen CLC Genomics Workbench Premium 소프트웨어를 출시했습니다.
이 밖에도 기술 발전, 연구 활동 증가, 투자 확대, 만성 및 유전 질환 사례 증가, 인식 제고 등은 예측 기간 동안 세계 시장 성장을 촉진하는 추가적인 요인입니다.

숙련된 전문가 부족
숙련된 전문가 부족은 예측 기간 동안 세계 시장 성장을 저해할 것으로 예상됩니다. 또한, 시퀀싱과 관련된 윤리적 및 법적 제한 사항 역시 예측 기간 동안 세계 시장 성장을 저해하는 추가적인 요인입니다.

시장 세분화 분석
글로벌 전장 유전체 시퀀싱 시장은 제품, 유형, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
서비스 및 제품 부문이 시장을 주도할 것으로 예상됩니다.
새로운 유전체 시퀀싱 서비스의 시장 진입 증가와 저비용 유전체 시퀀싱의 확산으로 인해 해당 부문이 예측 기간 동안 글로벌 시장을 주도하며 성장을 견인하고 있습니다. 예를 들어, 2021년 2월 스탠퍼드 의대는 심혈관 질환을 비롯한 질병의 원인을 규명하고 표적 치료법을 식별하는 데 도움을 주는 자체 전장 유전체 시퀀싱 서비스를 도입했습니다. 또한, 2020년 2월 네뷸라 지노믹스는 소비자가 직접 299달러에 이용할 수 있는 저렴한 전장 유전체 시퀀싱 서비스를 출시했습니다.
지역 분석
북미, 세계 시장 주도 예상
연구 발전과 일루미나(Illumina, Inc.)와 같은 주요 기업들의 존재로 인해 북미는 예측 기간 동안 세계 시장을 주도할 것으로 예상됩니다. 이들 기업은 잘 구축된 연구 개발 및 제조 시설을 보유하고 있으며, 차별화된 마케팅 전략을 통해 세계 시장의 대부분을 장악하고 있습니다.
예를 들어, 2022년 3월, 미국에 본사를 둔 유전자 분석 기업의 연구원들은 체외 수정(IVF)을 통해 생성된 배아의 거의 모든 DNA를 해독할 수 있다고 발표하는 획기적인 성과를 거두었습니다. 또한, 2021년 11월 일루미나와 제네틱 얼라이언스는 1억 2천만 달러 규모의 다국적 프로젝트인 iHope 유전 건강 프로그램을 시작했습니다. 이 프로젝트는 전 세계 유전 질환 환자들에게 전장 유전체 시퀀싱(WGS) 접근성을 제공하는 것을 목표로 합니다.
COVID-19 영향 분석
팬데믹에 대응하여 유전체 시퀀싱 사용이 증가하면서 시장에 긍정적인 영향을 미쳤습니다. 예를 들어, 영국 정부는 2022년 3월 SARS-CoV-2 바이러스의 유전체 시퀀싱을 위해 COVID-19 유전체 영국 컨소시엄을 출범시켰습니다. 이 컨소시엄은 바이러스 확산 경로 파악을 위해 약 2,200만 달러(2,000만 유로)의 투자를 받았습니다. 또한, 미 국방부는 COVID-19 팬데믹에 대응하여 2022년 12월 SARS-CoV-2 전장 유전체 시퀀싱 행동 계획을 수립했습니다.

시장 세분화
제품별
• 기기
• 소모품
• 서비스
유형별
• 대규모 전장 유전체 시퀀싱
• 소규모 전장 유전체 시퀀싱
• 기타
응용 분야별
• 진단
• 신약 개발
• 정밀 의학
• 역학 연구
• 기타
최종 사용자별
• 학술 및 연구 기관
• 병원 및 진단 센터
• 제약 및 생명공학 회사
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
• 2023년 10월, 대규모 유전체 데이터 분석 및 해석을 위한 소프트웨어 및 솔루션을 제공하는 디지털 헬스 기업인 Congenica는 계약 기간을 2년 연장했습니다. • 홍콩 최초의 대규모 게놈 시퀀싱 프로젝트인 홍콩 게놈 프로젝트(HKGP)를 위해

• 2023년 10월, 고품질 고정밀 시퀀싱 솔루션 개발 선두 기업인 PacBio는 HiFi 전장 게놈 시퀀싱(WGS) 데이터 분석을 위한 완벽하고 표준화된 계산 방식인 PacBio WGS Variant Pipeline을 출시했습니다.

• 2021년 4월, Sedia Biosciences Corporation은 SARS-CoV-2 검체의 전장 게놈 시퀀싱을 제공하여 새로운 변이체를 식별하고 감시하는 Sedia COVID-19 전장 게놈 시퀀싱 서비스를 출시했습니다.

경쟁 환경
시장의 주요 글로벌 기업으로는 Illumina, Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore Technologies, QIAGEN, Agilent Technologies, PerkinElmer Genomics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, PACBIO 및 PierianDx가 있습니다.

보고서 구매 이유

• 제품, 유형, 응용 분야, 최종 사용자 및 지역별 글로벌 전체 게놈 시퀀싱 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 전체 게놈 시퀀싱 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 전체 게놈 시퀀싱 시장 보고서는 약 69개의 표, 69개의 그림, 184페이지 분량입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Whole Genome Sequencing market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Specifying the order of bases is called sequencing. Whole genome sequencing is a laboratory process that specifies the order of bases in the genome of an organism in one operation. Whole-genome sequencing (WGS) is a complete technique for analyzing complete genomes. Genomic data has been instrumental in determining inherited conditions, marking the mutations that cause cancer advancement, and tracking infection outbreaks.
Market Dynamics: Drivers & Restraints
Increasing Advanced Products Introductions
The increasing advanced products introductions into the market is expected to boost the global market growth during the forecast period. For instance, in September 2022, Illumina, Inc. introduced its NovaSeq X series platforms, including NovaSeq X Plus and NovaSeq X. The production-scale sequencers can yield around 20,000 whole genomes in a year, which delivers 2.5 times better throughput than existing sequencers. Moreover, in January 2023, Qiagen Digital Insights (QDI) introduced Qiagen CLC Genomics Workbench Premium software that analyses the whole genome data in 25 minutes for almost USD 1 in cloud computing costs.
Furthermore, the technological advancements, rise in research activities, increaseing investments, growing cases of chronic and heridaitery conditions and increaseing awareness are among the other additional factors boosting the global market growth during the forecast period.
Lack of Skilled Professionals
The lack of skilled professionals is expected to hamper the global market growth during the forecast period. Furthermore, the the ethical and legal limitaions associated with sequencing are other additional factors hampering the global market growth during the forecast period.
Segment Analysis
The global whole genome sequencing market is segmented based on product, type, application, end user and region.
Services Products are Expected to Dominate Market
Owing to the increase in the introductions of new genome sequencing services into the market and the low-cost genome sequencing are boosting the segment growth dominating the global market during the forecast period. For instance, in February 2021, Stanford Medicine introduced its whole genome sequencing in-house service for the detection of the reason for disorders, particularly cardiovascular disease, and assists in the identification of target therapies. Moreover, in February 2020, Nebula Genomics introduced a lower-cost whole genome sequencing service, which is obtainable direct-to-consumer at USD 299.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the research advancements and the presence of major players such as Illumina, Inc., with well-established R&D and manufacturing facilities in the region holding the majority of the global market through distinct market tactics, ensures North America's dominance on the global market in the forecast period.
For instance, in March 2022, in a substantial breakthrough, researchers at a US-based gene analytics corporation asserted that they could decode nearly all the DNA of days-old embryos produced through in vitro fertilization (IVF). Moreover, in November 2021, Illumina and Genetic Alliance began a USD 120 million multinational endeavor the iHope Genetic Health program. This endeavor seeks to present Whole Genome Sequencing (WGS) access to diverse individuals affected by genetic conditions worldwide.
COVID-19 Impact Analysis
The increased use of genomic sequencing in response to the pandemic has had a positive impact on the market. One example of this is the COVID-19 Genomics U.K. Consortium, which was launched by the U.K. Government in March 2022 to sequence the genomes of the SARS-CoV-2 virus. The consortium received an investment of approximately USD 22 million (EUR 20 million) to map the spread of the virus. Additionally, the Department of Defense developed a SARS-CoV-2 Whole Genome Sequencing Action Plan in December 2022, in response to the COVID-19 pandemic.
Market Segmentation
By Product
• Instruments
• Consumables
• Services
By Type
• Large Whole Genome Sequencing
• Small Whole Genome Sequencing
• Other
By Application
• Diagnostics
• Drug Discovery
• Precision Medicine
• Epidemiological Studies
• Others
By End User
• Academic & Research Institutes
• Hospitals and Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In October 2023 Congenica, a digital health corporation delivering software and solutions for the analysis and interpretation of genomic data at scale, expanded its contract by 2 years for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in Hong Kong.
• In October 2023, PacBio, a top developer of high-quality, highly precise sequencing solutions, introduced PacBio WGS Variant Pipeline, a complete, standardized computational approach for HiFi whole genome sequencing (WGS) data analysis.
• In April 2021, Sedia Biosciences Corporation introduced the Sedia COVID-19 whole genome sequencing service, which delivers whole genome sequencing of SARS-CoV-2 specimens for the identification of novel variants and their surveillance.
Competitive Landscape
The major global players in the market include Illumina; Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore Technologies, QIAGEN, Agilent Technologies, PerkinElmer Genomics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, PACBIO and PierianDx.
Why Purchase the Report?
• To visualize the global whole genome sequencing market segmentation based on product, type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of whole genome sequencing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global whole genome sequencing market report would provide approximately 69 tables, 69 figures and 184 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by Type
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Advanced Products Introductions
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Lack of Skilled Professionals
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Technology and Trend Analysis
5.6. Unmet Needs
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Instruments*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Consumables
7.4. Services
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Diagnostics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Drug Discovery
8.4. Precision Medicine
8.5. Epidemiological Studies
8.6. Others
9. By Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.2. Market Attractiveness Index, By Type
9.2. Large Whole Genome Sequencing*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Small Whole Genome Sequencing
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Academic & Research Institutes*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Hospitals and Diagnostic Centers
10.4. Pharmaceutical & Biotechnology Companies
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Illumina; Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Thermo Fisher Scientific, Inc.
13.3. Oxford Nanopore Technologies, Inc.
13.4. QIAGEN
13.5. Agilent Technologies
13.6. PerkinElmer Genomics,
13.7. Bio-Rad Laboratories, Inc.
13.8. F. Hoffmann-La Roche Ltd,
13.9. PACBIO
13.10. PierianDx
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Illumina; Inc., 4.	Key Developments, Thermo Fisher Scientific, Inc., Oxford Nanopore Technologies, Inc., QIAGEN, Agilent Technologies, PerkinElmer Genomics,, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd,, PACBIO, PierianDx

표 목록 (Tables)

List of Tables

Table 1 Global Whole Genome Sequencing Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Whole Genome Sequencing Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Whole Genome Sequencing Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Whole Genome Sequencing Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Whole Genome Sequencing Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Whole Genome Sequencing Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Whole Genome Sequencing Market Value, By Product, 2022-2031 (US$ Million)

Table 8 Global Whole Genome Sequencing Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Whole Genome Sequencing Market Value, By Type, 2022-2031 (US$ Million)

Table 10 Global Whole Genome Sequencing Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Whole Genome Sequencing Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Whole Genome Sequencing Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Whole Genome Sequencing Market Value, By End User, 2022-2031 (US$ Million)

Table 14 Global Whole Genome Sequencing Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Whole Genome Sequencing Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Whole Genome Sequencing Market Value, By Product, 2022-2031 (US$ Million)

Table 17 North America Whole Genome Sequencing Market Value, By Type, 2022-2031 (US$ Million)

Table 18 North America Whole Genome Sequencing Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Whole Genome Sequencing Market Value, By End User, 2022-2031 (US$ Million)

Table 20 North America Whole Genome Sequencing Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Whole Genome Sequencing Market Value, By Product, 2022-2031 (US$ Million)

Table 22 South America Whole Genome Sequencing Market Value, By Type, 2022-2031 (US$ Million)

Table 23 South America Whole Genome Sequencing Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Whole Genome Sequencing Market Value, By End User, 2022-2031 (US$ Million)

Table 25 South America Whole Genome Sequencing Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Whole Genome Sequencing Market Value, By Product, 2022-2031 (US$ Million)

Table 27 Europe Whole Genome Sequencing Market Value, By Type, 2022-2031 (US$ Million)

Table 28 Europe Whole Genome Sequencing Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Whole Genome Sequencing Market Value, By End User, 2022-2031 (US$ Million)

Table 30 Europe Whole Genome Sequencing Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Whole Genome Sequencing Market Value, By Product, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Whole Genome Sequencing Market Value, By Type, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Whole Genome Sequencing Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Whole Genome Sequencing Market Value, By End User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Whole Genome Sequencing Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa Whole Genome Sequencing Market Value, By Product, 2022-2031 (US$ Million)

Table 37 Middle East & Africa Whole Genome Sequencing Market Value, By Type, 2022-2031 (US$ Million)

Table 38 Middle East & Africa Whole Genome Sequencing Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa Whole Genome Sequencing Market Value, By End User, 2022-2031 (US$ Million)

Table 40 Illumina; Inc.: Overview

Table 41 Illumina; Inc.: Product Portfolio

Table 42 Illumina; Inc.: Key Developments

Table 43 Thermo Fisher Scientific, Inc.: Overview

Table 44 Thermo Fisher Scientific, Inc.: Product Portfolio

Table 45 Thermo Fisher Scientific, Inc.: Key Developments

Table 46 Oxford Nanopore Technologies, Inc.: Overview

Table 47 Oxford Nanopore Technologies, Inc.: Product Portfolio

Table 48 Oxford Nanopore Technologies, Inc.: Key Developments

Table 49 QIAGEN: Overview

Table 50 QIAGEN: Product Portfolio

Table 51 QIAGEN: Key Developments

Table 52 Agilent Technologies: Overview

Table 53 Agilent Technologies: Product Portfolio

Table 54 Agilent Technologies: Key Developments

Table 55 PerkinElmer Genomics,: Overview

Table 56 PerkinElmer Genomics,: Product Portfolio

Table 57 PerkinElmer Genomics,: Key Developments

Table 58 Bio-Rad Laboratories, Inc.: Overview

Table 59 Bio-Rad Laboratories, Inc.: Product Portfolio

Table 60 Bio-Rad Laboratories, Inc.: Key Developments

Table 61 F. Hoffmann-La Roche Ltd,: Overview

Table 62 F. Hoffmann-La Roche Ltd,: Product Portfolio

Table 63 F. Hoffmann-La Roche Ltd,: Key Developments

Table 64 PACBIO: Overview

Table 65 PACBIO: Product Portfolio

Table 66 PACBIO: Key Developments

Table 67 PierianDx: Overview

Table 68 PierianDx: Product Portfolio

Table 69 PierianDx: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 2 Global Whole Genome Sequencing Market Share, By Product, 2022 & 2031 (%)

Figure 3 Global Whole Genome Sequencing Market Share, By Type, 2022 & 2031 (%)

Figure 4 Global Whole Genome Sequencing Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global Whole Genome Sequencing Market Share, By End User, 2022 & 2031 (%)

Figure 6 Global Whole Genome Sequencing Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global Whole Genome Sequencing Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 8 Instruments Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 9 Consumables Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 10 Services Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 11 Global Whole Genome Sequencing Market Y-o-Y Growth, By Type, 2022-2031 (%)

Figure 12 Large Whole Genome Sequencing Type in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 13 Small Whole Genome Sequencing Type in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 14 Global Whole Genome Sequencing Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 15 Diagnostics Application in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 16 Drug Discovery Application in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 17 Precision Medicine Application in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 18 Epidemiological Studies Application in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 19 Others Application in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 20 Global Whole Genome Sequencing Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 21 Academic & Research Institutes End User in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 22 Hospitals and Diagnostic Centers End User in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 23 Pharmaceutical & Biotechnology Companies End User in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 24 Others End User in Global Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 25 Global Whole Genome Sequencing Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 26 North America Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 27 Asia-Pacific Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 28 Europe Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 29 South America Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 30 Middle East and Africa Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 31 North America Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 32 North America Whole Genome Sequencing Market Share, By Product, 2022 & 2031 (%)

Figure 33 North America Whole Genome Sequencing Market Share, By Type, 2022 & 2031 (%)

Figure 34 North America Whole Genome Sequencing Market Share, By Application, 2022 & 2031 (%)

Figure 35 North America Whole Genome Sequencing Market Share, By End User, 2022 & 2031 (%)

Figure 36 North America Whole Genome Sequencing Market Share, By Country, 2022 & 2031 (%)

Figure 37 South America Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 38 South America Whole Genome Sequencing Market Share, By Product, 2022 & 2031 (%)

Figure 39 South America Whole Genome Sequencing Market Share, By Type, 2022 & 2031 (%)

Figure 40 South America Whole Genome Sequencing Market Share, By Application, 2022 & 2031 (%)

Figure 41 South America Whole Genome Sequencing Market Share, By End User, 2022 & 2031 (%)

Figure 42 South America Whole Genome Sequencing Market Share, By Country, 2022 & 2031 (%)

Figure 43 Europe Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 44 Europe Whole Genome Sequencing Market Share, By Product, 2022 & 2031 (%)

Figure 45 Europe Whole Genome Sequencing Market Share, By Type, 2022 & 2031 (%)

Figure 46 Europe Whole Genome Sequencing Market Share, By Application, 2022 & 2031 (%)

Figure 47 Europe Whole Genome Sequencing Market Share, By End User, 2022 & 2031 (%)

Figure 48 Europe Whole Genome Sequencing Market Share, By Country, 2022 & 2031 (%)

Figure 49 Asia-Pacific Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 50 Asia-Pacific Whole Genome Sequencing Market Share, By Product, 2022 & 2031 (%)

Figure 51 Asia-Pacific Whole Genome Sequencing Market Share, By Type, 2022 & 2031 (%)

Figure 52 Asia-Pacific Whole Genome Sequencing Market Share, By Application, 2022 & 2031 (%)

Figure 53 Asia-Pacific Whole Genome Sequencing Market Share, By End User, 2022 & 2031 (%)

Figure 54 Asia-Pacific Whole Genome Sequencing Market Share, By Country, 2022 & 2031 (%)

Figure 55 Middle East & Africa Whole Genome Sequencing Market Value, 2022-2031 (US$ Million)

Figure 56 Middle East & Africa Whole Genome Sequencing Market Share, By Product, 2022 & 2031 (%)

Figure 57 Middle East & Africa Whole Genome Sequencing Market Share, By Type, 2022 & 2031 (%)

Figure 58 Middle East & Africa Whole Genome Sequencing Market Share, By Application, 2022 & 2031 (%)

Figure 59 Middle East & Africa Whole Genome Sequencing Market Share, By End User, 2022 & 2031 (%)

Figure 60 Illumina; Inc.: Financials

Figure 61 Thermo Fisher Scientific, Inc.: Financials

Figure 62 Oxford Nanopore Technologies, Inc.: Financials

Figure 63 QIAGEN: Financials

Figure 64 Agilent Technologies: Financials

Figure 65 PerkinElmer Genomics,: Financials

Figure 66 Bio-Rad Laboratories, Inc.: Financials

Figure 67 F. Hoffmann-La Roche Ltd,: Financials

Figure 68 PACBIO: Financials

Figure 69 PierianDx: Financials

글로벌 전체 게놈 시퀀싱 시장 – 2023-2030

Global Whole Genome Sequencing Market - 2023-2030